(Q41474758)

1 October 2017

Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs (English)

1 reference

1 October 2017

0 references

1 reference

White RA

1

1 reference

PMCID

2010189

1 October 2017

Workman P

series ordinal

2

1 reference

PMCID

2010189

1 October 2017

language of work or name

English

0 references

publication date

1 February 1980

1 reference

British Journal of Cancer

1 October 2017

1 reference

1 October 2017

41

1 reference

1 October 2017

2

1 reference

1 October 2017

268-276

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1980.39

1 October 2017

0 references

cites work

Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

Distribution of misonidazole in human tumours and normal tissues

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

A metabolite of the 2-nitroimidazole misonidazole with radiosensitizing properties

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

The penetration of misonidazole into spontaneous canine tumours

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

Clinical studies with misonidazole

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

The rationale for the development of improved hypoxic cell radiosensitizers

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010189

Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers

11 June 2018

1 reference

12 December 2020

Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative

1 reference

12 December 2020

Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

The pharmacokinetics of misonidazole in the dog

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1980.39

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

PMCID

2010189